Netherlands to India: Ras Import Trade Route

The Netherlands to India Ras corridor is one of India's established pharmaceutical import routes from Netherlands, with 8 shipments documented worth a combined $178.0K USD. The route is dominated by XXacuXXMedXXineXXharXX SeXXiceXXLtdX, which alone accounts for roughly 68% of all import value, reflecting the consolidated nature of Netherlands's ras export sector.

Across 6 active Netherlands suppliers, the average shipment value stands at $22.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with ras's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 14.6%, placing it at rank #1 among India's top ras import origins globally.

On the Indian buyer side, key Indian importers include FISHER BIOPHARMA SERVICES INDIA PVT LTD, INTAS PHARMACEUTICALS LIMITED , INTAS PHARMACEUTICALS LIMITED and 2 others. FISHER BIOPHARMA SERVICES INDIA PVT LTD is the single largest Indian importer with 1 shipments valued at $121.4K USD.

India's ras imports from Netherlands are driven primarily by a handful of large-scale Netherlands manufacturers. XXacuXXMedXXineXXharXX SeXXiceXXLtdX with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — Indian buyers benefit from Netherlands supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — XXacuXXMedXXineXXharXX SeXXiceXXLtdX, NEW LIFE MEDICALS LLC , ABACUS MEDICINE PHARMA SERVICES LTD — together account for 97% of total trade value on this route. The average shipment value of $22.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as for clinical trial-filgrastim solution for injecti on 300 mcg/0.5ml (neupogen singleject)-(pack of pfs to debit 82 x 5 and trastuzumab solution for injection (herceptin) (3 packs x 3vials = 3 vials) , suggesting that Indian buyers tend to consolidate orders across related product lines from the same Netherlands supplier.

On the buying side, FISHER BIOPHARMA SERVICES INDIA PVT LTD is the largest importer with 1 shipments worth $121.4K USD — representing 68% of all ras imports from Netherlands on this route.